{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:03:02Z","timestamp":1794546182823,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP9-229-3-041"],"award-info":[{"award-number":["NPRP9-229-3-041"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019475","name":"Sidra Medicine","doi-asserted-by":"publisher","award":["SDR100002"],"award-info":[{"award-number":["SDR100002"]}],"id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019475","name":"Sidra Medical and Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at 17% double the global average. MicroRNAs (miRNAs) are implicated in the pathogenesis of (T2D) and long-term microvascular complications including diabetic retinopathy (DR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a T2D cohort that accurately matches the characteristics of the general population was employed to find microRNA (miRNA) signatures that are correlated with glycemic and \u03b2 cell function measurements. Targeted miRNA profiling was performed in (471) T2D individuals with or without DR and (491) (non-diabetic) healthy controls from the Qatar Biobank. Discovery analysis identified 20 differentially expressed miRNAs in T2D compared to controls, of which miR-223-3p was significantly upregulated (fold change:5.16, p\u2009=\u20093.6e\u221202) and positively correlated with glucose and hemoglobin A1c (HbA1c) levels (p-value\u2009=\u20099.88e\u221204 and 1.64e\u221205, respectively), but did not show any significant associations with insulin or C-peptide. Accordingly, we performed functional validation using a miR-223-3p mimic (overexpression) under control and hyperglycemia-induced conditions in a zebrafish model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over-expression of miR-223-3p alone was associated with significantly higher glucose (42.7\u00a0mg\/dL, n\u2009=\u200975 vs 38.7\u00a0mg\/dL, n\u2009=\u200975, p\u2009=\u20090.02) and degenerated retinal vasculature, and altered retinal morphology involving changes in the ganglion cell layer and inner and outer nuclear layers. Assessment of retinal angiogenesis revealed significant upregulation in the expression of vascular endothelial growth factor and its receptors, including kinase insert domain receptor. Further, the pancreatic markers, pancreatic and duodenal homeobox 1, and the insulin gene expressions were upregulated in the miR-223-3p group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our zebrafish model validates a novel correlation between miR-223-3p and DR development. Targeting miR-223-3p in T2D patients may serve as a promising therapeutic strategy to control DR in at-risk individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-03893-2","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T11:03:08Z","timestamp":1677841388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature"],"prefix":"10.1186","volume":"21","author":[{"given":"Sahar I.","family":"Da\u2019as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlak","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem H.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doua A.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbay","family":"Aliyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz Ahmad","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugdha V.","family":"Joglekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandwardhan A.","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Fakhro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-070X","authenticated-orcid":false,"given":"Ammira S. Al-Shabeeb","family":"Akil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"23","key":"3893_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","volume":"328","author":"DM Nathan","year":"1993","unstructured":"Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676\u201385.","journal-title":"N Engl J Med"},{"key":"3893_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157: 107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"3893_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.diabres.2013.11.008","volume":"103","author":"A Majeed","year":"2014","unstructured":"Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf S. Diabetes in the Middle-East and North Africa: an update. Diabetes Res Clin Pract. 2014;103(2):218\u201322.","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"3893_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339.","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"3893_CR5","doi-asserted-by":"publisher","first-page":"s84","DOI":"10.2337\/diacare.27.2007.S84","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):s84\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"3893_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4103\/1673-5374.205095","volume":"12","author":"E-A Ye","year":"2017","unstructured":"Ye E-A, Steinle JJ. Regulatory role of microRNA on inflammatory responses of diabetic retinopathy. Neural Regen Res. 2017;12(4):580.","journal-title":"Neural Regen Res"},{"key":"3893_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107840","volume":"157","author":"R Thomas","year":"2019","unstructured":"Thomas R, Halim S, Gurudas S, Sivaprasad S, Owens D. IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019;157: 107840.","journal-title":"Diabetes Res Clin Pract"},{"key":"3893_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1874364101307010004","volume":"7","author":"N Gupta","year":"2013","unstructured":"Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M. Diabetic retinopathy and VEGF. Open Ophthalmol J. 2013;7:4.","journal-title":"Open Ophthalmol J"},{"issue":"3","key":"3893_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","volume":"78","author":"HC Gerstein","year":"2007","unstructured":"Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305\u201312.","journal-title":"Diabetes Res Clin Pract"},{"key":"3893_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fendo.2018.00459","volume":"9","author":"C Peng","year":"2018","unstructured":"Peng C, Wang Y-L. microRNAs as new players in endocrinology. Front Endocrinol. 2018;9:459.","journal-title":"Front Endocrinol"},{"key":"3893_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6890501","author":"F Barutta","year":"2018","unstructured":"Barutta F, Bellini S, Mastrocola R, Bruno G, Gruden G. MicroRNA and microvascular complications of diabetes. Int J Endocrinol. 2018. https:\/\/doi.org\/10.1155\/2018\/6890501.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"3893_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.diabres.2013.03.010","volume":"101","author":"A Zabetian","year":"2013","unstructured":"Zabetian A, Kelli HM, Echouffo-Tcheugui JB, Narayan KM, Ali MK. Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract. 2013;101(2):106\u201322.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"3893_CR13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2337\/db05-1634","volume":"55","author":"D Dobler","year":"2006","unstructured":"Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ. Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes. 2006;55(7):1961\u20139.","journal-title":"Diabetes"},{"key":"3893_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-51436-9_2","volume-title":"Kidney development and disease","author":"RW Naylor","year":"2017","unstructured":"Naylor RW, Qubisi SS, Davidson AJ. Zebrafish pronephros development. In: Kidney development and disease. Cham: Springer; 2017. p. 27\u201353."},{"issue":"2","key":"3893_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2337\/dc13-0954","volume":"37","author":"AB Dart","year":"2014","unstructured":"Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014;37(2):436\u201343.","journal-title":"Diabetes Care"},{"issue":"7446","key":"3893_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496(7446):498\u2013503.","journal-title":"Nature"},{"key":"3893_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18092002","author":"K Heckler","year":"2017","unstructured":"Heckler K, Kroll J. Zebrafish as a model for the study of microvascular complications of diabetes and their mechanisms. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18092002.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3893_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/zeb.2009.0640","volume":"7","author":"SC Eames","year":"2010","unstructured":"Eames SC, Philipson LH, Prince VE, Kinkel MD. Blood sugar measurement in zebrafish reveals dynamics of glucose homeostasis. Zebrafish. 2010;7(2):205\u201313.","journal-title":"Zebrafish"},{"issue":"3","key":"3893_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/1753-0407.12860","volume":"11","author":"J Krishnan","year":"2019","unstructured":"Krishnan J, Rohner N. Sweet fish: fish models for the study of hyperglycemia and diabetes. J Diabetes. 2019;11(3):193\u2013203.","journal-title":"J Diabetes"},{"issue":"3","key":"3893_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00592-007-0257-3","volume":"44","author":"M Gleeson","year":"2007","unstructured":"Gleeson M, Connaughton V, Arneson L. Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol. 2007;44(3):157\u201363.","journal-title":"Acta Diabetol"},{"issue":"1","key":"3893_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6793-10-21","volume":"10","author":"T Oka","year":"2010","unstructured":"Oka T, et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010;10(1):1\u201313.","journal-title":"BMC Physiol"},{"issue":"1","key":"3893_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12899-017-0031-x","volume":"17","author":"K Landgraf","year":"2017","unstructured":"Landgraf K, Schuster S, Meusel A, Garten A, Riemer T, Schleinitz D, Kiess W, K\u00f6rner A. Short-term overfeeding of zebrafish with normal or high-fat diet as a model for the development of metabolically healthy versus unhealthy obesity. BMC Physiol. 2017;17(1):1\u201310.","journal-title":"BMC Physiol"},{"key":"3893_CR23","first-page":"531","volume-title":"Methods in cell biology","author":"L Gn\u00fcgge","year":"2004","unstructured":"Gn\u00fcgge L, Meyer D, Driever W. Pancreas development in zebrafish. In: Methods in cell biology. San Diego: Academic Press; 2004. p. 531\u201351."},{"key":"3893_CR24","first-page":"273","volume":"103","author":"NS Yee","year":"2005","unstructured":"Yee NS, Pack M. Zebrafish as a model for pancreatic cancer research. Methods Mol Med. 2005;103:273\u201398.","journal-title":"Methods Mol Med"},{"key":"3893_CR25","first-page":"273","volume-title":"Pancreatic cancer: methods and protocols","author":"NS Yee","year":"2005","unstructured":"Yee NS, Pack M. Zebrafish as a model for pancreatic cancer research. In: Su GH, editor. Pancreatic cancer: methods and protocols. Totowa: Humana Press; 2005. p. 273\u201398."},{"issue":"11","key":"3893_CR26","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1073\/pnas.1513212113","volume":"113","author":"M Michel","year":"2016","unstructured":"Michel M, Page-McCaw PS, Chen W, Cone RD. Leptin signaling regulates glucose homeostasis, but not adipostasis, in the zebrafish. Proc Natl Acad Sci. 2016;113(11):3084\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3893_CR27","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.1152\/ajpendo.00227.2017","volume":"315","author":"B-Y Yang","year":"2018","unstructured":"Yang B-Y, et al. Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. Am J Physiol Endocrinol Metab. 2018;315(1):E38\u201351.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"3893_CR28","doi-asserted-by":"publisher","first-page":"E662","DOI":"10.1152\/ajpendo.00441.2014","volume":"308","author":"LA Maddison","year":"2015","unstructured":"Maddison LA, Joest KE, Kammeyer RM, Chen W. Skeletal muscle insulin resistance in zebrafish induces alterations in \u03b2-cell number and glucose tolerance in an age- and diet-dependent manner. Am J Physiol Endocrinol Metab. 2015;308(8):E662\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3893_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110541","volume":"498","author":"J Shao","year":"2019","unstructured":"Shao J, Fan G, Yin X, Gu Y, Wang X, Xin Y, Yao Y. A novel transthyretin\/STAT4\/miR-223-3p\/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy. Mol Cell Endocrinol. 2019;498: 110541.","journal-title":"Mol Cell Endocrinol"},{"issue":"27","key":"3893_CR30","doi-asserted-by":"publisher","first-page":"10438","DOI":"10.1074\/jbc.RA119.007755","volume":"294","author":"Y Li","year":"2019","unstructured":"Li Y, Deng S, Peng J, Wang X, Essandoh K, Mu X, Peng T, Meng Z-X, Fan G-C. MicroRNA-223 is essential for maintaining functional \u03b2-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways. J Biol Chem. 2019;294(27):10438\u201348.","journal-title":"J Biol Chem"},{"key":"3893_CR31","first-page":"2950","volume":"10","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Li D, Chen D, Ji H, Hu Q, Zhang J. Increased miR-223 expression promotes proliferation and migration of retinal endothelial cells and pathogenesis of diabetic retinopathy by targeting EIF4E3 and IGF-1R. Int J Clin Exp Pathol. 2017;10:2950\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"3893_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fcell.2018.00091","volume":"6","author":"L Zang","year":"2018","unstructured":"Zang L, Maddison LA, Chen W. Zebrafish as a model for obesity and diabetes. Front Cell Dev Biol. 2018;6:91.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3893_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/1074248420922793","volume":"25","author":"JY Barraclough","year":"2020","unstructured":"Barraclough JY, Joglekar MV, Januszewski AS, Martinez G, Celermajer DS, Keech AC, Hardikar AA, Patel S. A microRNA signature in acute coronary syndrome patients and modulation by colchicine. J Cardiovasc Pharmacol Ther. 2020;25(5):444\u201355.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"3893_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102379","volume":"24","author":"WKM Wong","year":"2021","unstructured":"Wong WKM, et al. Machine learning workflows identify a microRNA signature of insulin transcription in human tissues. iScience. 2021;24(4): 102379.","journal-title":"iScience"},{"issue":"1","key":"3893_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/dbi15-0028","volume":"65","author":"MV Joglekar","year":"2016","unstructured":"Joglekar MV, Januszewski AS, Jenkins AJ, Hardikar AA. Circulating microRNA biomarkers of diabetic retinopathy. Diabetes. 2016;65(1):22\u20134.","journal-title":"Diabetes"},{"issue":"7","key":"3893_CR36","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1007\/s00125-021-05429-z","volume":"64","author":"MV Joglekar","year":"2021","unstructured":"Joglekar MV, Wong WKM, Ema FK, Georgiou HM, Shub A, Hardikar AA, Lappas M. Postpartum circulating microRNA enhances prediction of future type 2 diabetes in women with previous gestational diabetes. Diabetologia. 2021;64(7):1516\u201326.","journal-title":"Diabetologia"},{"key":"3893_CR37","doi-asserted-by":"publisher","DOI":"10.3791\/52586","author":"W Wong","year":"2015","unstructured":"Wong W, Farr R, Joglekar M, Januszewski A, Hardikar A. Probe-based real-time PCR approaches for quantitative measurement of microRNAs. J Vis Exp. 2015. https:\/\/doi.org\/10.3791\/52586.","journal-title":"J Vis Exp"},{"key":"3893_CR38","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4473","volume":"6","author":"M Ahmed","year":"2018","unstructured":"Ahmed M, Kim DR. pcr: an R package for quality assessment, analysis and testing of qPCR data. PeerJ. 2018;6: e4473.","journal-title":"PeerJ"},{"issue":"5","key":"3893_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00204-020-02679-5","volume":"94","author":"F Shihana","year":"2020","unstructured":"Shihana F, Joglekar MV, Raubenheimer J, Hardikar AA, Buckley NA, Seth D. Circulating human microRNA biomarkers of oxalic acid-induced acute kidney injury. Arch Toxicol. 2020;94(5):1725\u201337.","journal-title":"Arch Toxicol"},{"issue":"4","key":"3893_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"3893_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/B978-0-12-812431-4.00038-5","volume-title":"The zebrafish in biomedical research","author":"SC Cartner","year":"2020","unstructured":"Cartner SC, Durboraw E, Watts A. Regulations, policies and guidelines pertaining to the use of zebrafish in biomedical research. In: The zebrafish in biomedical research. London: Elsevier; 2020. p. 451\u20139."},{"key":"3893_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101418","volume":"8","author":"D Abdelrahman","year":"2021","unstructured":"Abdelrahman D, Hasan W, Da\u2019as SI. Microinjection quality control in zebrafish model for genetic manipulations. MethodsX. 2021;8: 101418.","journal-title":"MethodsX"},{"issue":"8","key":"3893_CR43","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/cells9081782","volume":"9","author":"SI Da'as","year":"2020","unstructured":"Da\u2019as SI, et al. PGAP3 associated with hyperphosphatasia with mental retardation plays a novel role in brain morphogenesis and neuronal wiring at early development. Cells. 2020;9(8):1782.","journal-title":"Cells"},{"issue":"8","key":"3893_CR44","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/aje\/kwz084","volume":"188","author":"A Al Thani","year":"2019","unstructured":"Al Thani A, Fthenou E, Paparrodopoulos S, Al Marri A, Shi Z, Qafoud F, Afifi N. Qatar biobank cohort study: study design and first results. Am J Epidemiol. 2019;188(8):1420\u201333.","journal-title":"Am J Epidemiol"},{"issue":"61","key":"3893_CR45","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.21105\/joss.03167","volume":"6","author":"I Patil","year":"2021","unstructured":"Patil I. Visualizations with statistical details: the \u2018ggstatsplot\u2019 approach. J Open Source Softw. 2021;6(61):3167. https:\/\/doi.org\/10.21105\/joss.03167.","journal-title":"J Open Source Softw"},{"issue":"9","key":"3893_CR46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2013.86","volume":"9","author":"C Guay","year":"2013","unstructured":"Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9(9):513.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"3893_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0194-y","volume":"50","author":"R Jim\u00e9nez-Lucena","year":"2018","unstructured":"Jim\u00e9nez-Lucena R, et al. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp Mol Med. 2018;50(12):1\u201312.","journal-title":"Exp Mol Med"},{"issue":"10","key":"3893_CR48","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1210\/endo.139.10.6245","volume":"139","author":"L Wu","year":"1998","unstructured":"Wu L, Fritz JD, Powers AC. Different functional domains of GLUT2 glucose transporter are required for glucose affinity and substrate specificity. Endocrinology. 1998;139(10):4205\u201312.","journal-title":"Endocrinology"},{"issue":"7","key":"3893_CR49","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.febslet.2012.02.050","volume":"586","author":"L Wu","year":"2012","unstructured":"Wu L, et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012;586(7):1038\u201343.","journal-title":"FEBS Lett"},{"key":"3893_CR50","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.omtn.2021.01.014","volume":"23","author":"J S\u00e1nchez-Ceinos","year":"2021","unstructured":"S\u00e1nchez-Ceinos J, Rangel-Zu\u00f1iga OA, Clemente-Postigo M, Podadera-Herreros A, Camargo A, Alcal\u00e1-Diaz JF, Guzm\u00e1n-Ruiz R, L\u00f3pez-Miranda J, Malag\u00f3n MM. miR-223-3p as a potential biomarker and player for adipose tissue dysfunction preceding type 2 diabetes onset. Mol Ther Nucleic Acids. 2021;23:1035\u201352.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"3893_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-90856-6","volume":"11","author":"AS Januszewski","year":"2021","unstructured":"Januszewski AS, et al. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Sci Rep. 2021;11(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"1","key":"3893_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1039\/C6MB00596A","volume":"13","author":"YON Lopez","year":"2017","unstructured":"Lopez YON, Garufi G, Seyhan AA. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol BioSyst. 2017;13(1):106\u201321.","journal-title":"Mol BioSyst"},{"issue":"1","key":"3893_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31479","volume":"6","author":"AA Seyhan","year":"2016","unstructured":"Seyhan AA, Nunez Lopez YO, Xie H, Yi F, Mathews C, Pasarica M, Pratley RE. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;6(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"2","key":"3893_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5339\/qmj.2012.2.10","volume":"2012","author":"ZM Abdulkader","year":"2012","unstructured":"Abdulkader ZM, Ur Rahman S, Nimeri N. The incidence of low birth weight and intrauterine growth restriction in relationship to maternal ethnicity and gestational age at birth\u2014a PEARL study analysis from the State of Qatar. Qatar Med J. 2012;2012(2):32\u20137.","journal-title":"Qatar Med J"},{"issue":"4","key":"3893_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40618-019-01129-z","volume":"43","author":"M Parrizas","year":"2020","unstructured":"Parrizas M, et al. miR-10b and miR-223-3p in serum microvesicles signal progression from prediabetes to type 2 diabetes. J Endocrinol Invest. 2020;43(4):451\u20139.","journal-title":"J Endocrinol Invest"},{"key":"3893_CR56","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fcell.2020.00516","volume":"8","author":"N Fernando","year":"2020","unstructured":"Fernando N, et al. MicroRNA-223 regulates retinal function and inflammation in the healthy and degenerating retina. Front Cell Dev Biol. 2020;8:516.","journal-title":"Front Cell Dev Biol"},{"key":"3893_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2020.101747","volume":"104","author":"Y Ou-Yang","year":"2020","unstructured":"Ou-Yang Y, Liu Z-L, Xu C-L, Wu J-L, Peng J, Peng Q-H. miR-223 induces retinal ganglion cells apoptosis and inflammation via decreasing HSP-70 in vitro and in vivo. J Chem Neuroanat. 2020;104: 101747.","journal-title":"J Chem Neuroanat"},{"issue":"Pt B","key":"3893_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med. 2015;88(Pt B):93\u2013100.","journal-title":"Free Radic Biol Med"},{"key":"3893_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117980","volume":"256","author":"D Xu","year":"2020","unstructured":"Xu D, Zhang X, Chen X, Yang S, Chen H. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy. Life Sci. 2020;256: 117980.","journal-title":"Life Sci"},{"key":"3893_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/943659","author":"T-Y Chuang","year":"2015","unstructured":"Chuang T-Y, Wu H-L, Chen C-C, Gamboa GM, Layman LC, Diamond MP, Azziz R, Chen Y-H. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J Diabetes Res. 2015. https:\/\/doi.org\/10.1155\/2015\/943659.","journal-title":"J Diabetes Res"},{"issue":"1\u20132","key":"3893_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2008.07.006","volume":"294","author":"AS Bernardo","year":"2008","unstructured":"Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic \u03b2 cell. Mol Cell Endocrinol. 2008;294(1\u20132):1\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"3893_CR62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/cells9020413","volume":"9","author":"A Galli","year":"2020","unstructured":"Galli A, Algerta M, Marciani P, Schulte C, Lenardi C, Milani P, Maffioli E, Tedeschi G, Perego C. Shaping pancreatic \u03b2-cell differentiation and functioning: the influence of mechanotransduction. Cells. 2020;9(2):413.","journal-title":"Cells"},{"issue":"5","key":"3893_CR63","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1159\/000445565","volume":"38","author":"T Zhou","year":"2016","unstructured":"Zhou T, et al. Regulation of insulin resistance by multiple MiRNAs via targeting the GLUT4 signalling pathway. Cell Physiol Biochem. 2016;38(5):2063\u201378.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"3893_CR64","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2337\/db19-0873","volume":"69","author":"LM Wiggenhauser","year":"2020","unstructured":"Wiggenhauser LM, et al. Activation of retinal angiogenesis in hyperglycemic pdx1\u2212\/\u2212 zebrafish mutants. Diabetes. 2020;69(5):1020\u201331.","journal-title":"Diabetes"},{"key":"3893_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mce.2016.03.019","volume":"428","author":"W Wang","year":"2016","unstructured":"Wang W, Shi Q, Guo T, Yang Z, Jia Z, Chen P, Zhou C. PDX1 and ISL1 differentially coordinate with epigenetic modifications to regulate insulin gene expression in varied glucose concentrations. Mol Cell Endocrinol. 2016;428:38\u201348.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"3893_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2225-4110.139109","volume":"4","author":"PK-K Lai","year":"2014","unstructured":"Lai PK-K, Chan JY-W, Kwok H-F, Cheng L, Yu H, Lau C-P, Leung P-C, Fung K-P, Bik-San Lau C. Induction of angiogenesis in zebrafish embryos and proliferation of endothelial cells by an active fraction isolated from the root of astragalus membranaceus using bioassay-guided fractionation. J Tradit Complement Med. 2014;4(4):239\u201345.","journal-title":"J Tradit Complement Med"},{"issue":"4","key":"3893_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/bjo.83.4.486","volume":"83","author":"G Smith","year":"1999","unstructured":"Smith G, McLeod D, Foreman D, Boulton M. Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br J Ophthalmol. 1999;83(4):486\u201394.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3893_CR68","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1167\/iovs.11-8997","volume":"53","author":"HW Van Dijk","year":"2012","unstructured":"Van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abramoff MD. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012;53(6):2715\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3893_CR69","first-page":"2429","volume":"15","author":"L Wan","year":"2018","unstructured":"Wan L, Yuan X, Liu M, Xue B. miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells. Exp Ther Med. 2018;15(3):2429\u201335.","journal-title":"Exp Ther Med"},{"issue":"4","key":"3893_CR70","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jdi.12312","volume":"6","author":"TS Kern","year":"2015","unstructured":"Kern TS, Berkowitz BA. Photoreceptors in diabetic retinopathy. J Diabetes Investig. 2015;6(4):371\u201380.","journal-title":"J Diabetes Investig"},{"issue":"9","key":"3893_CR71","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00125-003-1177-6","volume":"46","author":"S-H Park","year":"2003","unstructured":"Park S-H, Park J-W, Park S-J, Kim K-Y, Chung J-W, Chun M-H, Oh S-J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003;46(9):1260\u20138.","journal-title":"Diabetologia"},{"issue":"7","key":"3893_CR72","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.305510","volume":"116","author":"B Yan","year":"2015","unstructured":"Yan B, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116(7):1143\u201356.","journal-title":"Circ Res"},{"issue":"11","key":"3893_CR73","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1167\/iovs.14-15167","volume":"55","author":"Y Cao","year":"2014","unstructured":"Cao Y, Feng B, Chen S, Chu Y, Chakrabarti S. Mechanisms of endothelial to mesenchymal transition in the retina in diabetes. Invest Ophthalmol Vis Sci. 2014;55(11):7321\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3893_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbrc.2015.08.121","volume":"466","author":"J Wu","year":"2015","unstructured":"Wu J, Wang R, Ye Z, Sun X, Chen Z, Xia F, Sun Q, Liu L. Protective effects of methane-rich saline on diabetic retinopathy via anti-inflammation in a streptozotocin-induced diabetic rat model. Biochem Biophys Res Commun. 2015;466(2):155\u201361.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"3893_CR75","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.febslet.2015.03.010","volume":"589","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, Chen Q, Rajala RV, Ma JX. MicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization. FEBS Lett. 2015;589(10):1143\u20139.","journal-title":"FEBS Lett"},{"issue":"1","key":"3893_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7150\/ijms.7329","volume":"11","author":"P Ye","year":"2014","unstructured":"Ye P, Liu J, He F, Xu W, Yao K. Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression. Int J Med Sci. 2014;11(1):17\u201323.","journal-title":"Int J Med Sci"},{"issue":"12","key":"3893_CR77","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.cellsig.2013.08.039","volume":"25","author":"S Ling","year":"2013","unstructured":"Ling S, Birnbaum Y, Nanhwan MK, Thomas B, Bajaj M, Ye Y. MicroRNA-dependent cross-talk between VEGF and HIF1alpha in the diabetic retina. Cell Signal. 2013;25(12):2840\u20137.","journal-title":"Cell Signal"},{"issue":"3","key":"3893_CR78","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1167\/iovs.12-10921","volume":"54","author":"AR Murray","year":"2013","unstructured":"Murray AR, Chen Q, Takahashi Y, Zhou KK, Park K, Ma JX. MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci. 2013;54(3):1689\u201397.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3893_CR79","first-page":"2228","volume":"17","author":"VA Silva","year":"2011","unstructured":"Silva VA, Polesskaya A, Sousa TA, Correa VM, Andre ND, Reis RI, Kettelhut IC, Harel-Bellan A, De Lucca FL. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol Vis. 2011;17:2228\u201340.","journal-title":"Mol Vis"},{"issue":"7","key":"3893_CR80","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1167\/iovs.10-6879","volume":"52","author":"B Kovacs","year":"2011","unstructured":"Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2011;52(7):4402\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3893_CR81","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2337\/db10-1557","volume":"60","author":"K McArthur","year":"2011","unstructured":"McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes. 2011;60(4):1314\u201323.","journal-title":"Diabetes"},{"issue":"5","key":"3893_CR82","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00125-014-3197-9","volume":"57","author":"R Mortuza","year":"2014","unstructured":"Mortuza R, Feng B, Chakrabarti S. miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia. 2014;57(5):1037\u201346.","journal-title":"Diabetologia"},{"issue":"6","key":"3893_CR83","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1167\/iovs.15-16498","volume":"56","author":"N Garcia de laTorre","year":"2015","unstructured":"Garcia de laTorre N, et al. Expression of angiogenic microRNAs in endothelial progenitor cells from type 1 diabetic patients with and without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015;56(6):4090\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3893_CR84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00417-014-2692-5","volume":"253","author":"K Hirota","year":"2015","unstructured":"Hirota K, Keino H, Inoue M, Ishida H, Hirakata A. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(3):335\u201342.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3893_CR85","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1159\/000366374","volume":"34","author":"S Qing","year":"2014","unstructured":"Qing S, Yuan S, Yun C, Hui H, Mao P, Wen F, Ding Y, Liu Q. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cell Physiol Biochem. 2014;34(5):1733\u201340.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"3893_CR86","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2337\/db15-0389","volume":"65","author":"A Zampetaki","year":"2015","unstructured":"Zampetaki A, et al. Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes. Diabetes. 2015;65(1):216\u201327.","journal-title":"Diabetes"},{"key":"3893_CR87","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.1038\/srep10375","volume":"5","author":"RJ Farr","year":"2015","unstructured":"Farr RJ, et al. A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Sci Rep. 2015;5:10375.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03893-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03893-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03893-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:02:53Z","timestamp":1677844973000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03893-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03893-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2398478\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Qatar Biobank ethical approval: IRB protocol # E-2017-QF-QBB-RES-ACC-0026-0001, January 30th, 2022. Approval category: Expedited. (Dr. Khalid Al-Ansari, chairman, institutional Review Board QBB, QBB IRB MOPH Registration: IRB-QBB-2019-001 Email: qbbresearch@qf.org.qa QBB IRB MOPH Assurance: IRB-A-QBB-2019-0017). IACUC ethical approval: Institutional Animal Care and Use Committee (IACUC). Protocol Number: EVMC-2020-006. IACUC ethical approval: 2020-1132, Sidra Medicine Zebrafish Facility approval date: 06\/15\/2020, Expiry date: 06\/15\/2023. Sidra Medicine, IRB protocol #1871925, March 7th, 2022. Approval category: Exempt (research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available, or the investigator records the information in such a manner that the subjects cannot be identified directly or through identifiers linked to the subjects). Sidra IRB MOPH Assurance: IRB-A-Sidra-2019-0020 Sidra IRB MOPH Registration: IRB-Sidra-2020-009 Sidra IRB DHHS Assurance: FWA00022378. Sidra IRB DHHS Registration: IRB00009930. Tel: +\u2009974-4003-7747 Email: irb@sidra.org.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants included in the study through Qatar Biobank\u2014\u201cQBB Cohort Study QF-QBB-RES-ACC-0075 QBB IRB Approval number is: Full Board-2017-QF-QBB-RES-ACC-0075-0023. Deidentified research conducted under the project \u201cQF-QBB-RES-ACC-0026 QBB IRB Approval number, E-2017-QF-QBB-RES-ACC-0026-0001\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}